Oxidative Stress and Its Clinical Applications in Dementia

Abstract EN

Dementia is a complex disorder that mostly affects the elderly and represents a significant and growing public health burden in the world.

Alzheimer’s disease (AD)- associated dementia and dementia with Lewy bodies (DLB) are the most common forms of dementia, in which oxidative stress is significantly involved.

Oxidative stress mechanisms may have clinical applications, that is, providing information for potential biomarkers.

Thus brain-rich peptides with an antioxidant property, such as CART (cocaine- and amphetamine-regulated transcript), may be promising new markers.

This paper summarizes the progress in research regarding oxidative stress in dementia with a focus on potential biomarkers in the cerebrospinal fluid (CSF) in the main forms of dementia.

Other central and peripheral biomarkers, especially those considered oxidative stress related, are also discussed.

This paper aims to provide information to improve current understanding of the pathogenesis and progression of dementia.

It also offers insight into the differential diagnosis of AD and DLB.